UBS Maintains Neutral on Bath & Body Works, Lowers Price Target to $38
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Jay Sole has maintained a Neutral rating on Bath & Body Works (NYSE:BBWI) but has lowered the price target from $52 to $38.
August 29, 2024 | 12:41 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
UBS analyst Jay Sole has maintained a Neutral rating on Bath & Body Works but has lowered the price target from $52 to $38, indicating a less optimistic outlook.
The lowering of the price target from $52 to $38 by UBS suggests a less optimistic view on Bath & Body Works' future performance, which could lead to a negative short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100